131
TITLE: Efficacy and safety of opicapone in Parkinson's disease patients according to duration of motor fluctuations: post-hoc analysis of BIPARK-I and II  Full Text
AUTHORS: Ebersbach, G; Rascol, O; Ferreira, JJ; Costa, R; Rocha, JF; Magalhaes, D; Soares Da Silva, P;
PUBLISHED: 2020, SOURCE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
INDEXED IN: WOS
132
TITLE: Change in OFF-/ON-Time After Switching from Double-Blind Entacapone or Placebo to Open-Label Opicapone in Patients who Ended the 1-Year BIPARK-I Extension Study on Opicapone 50mg  Full Text
AUTHORS: Poewe, W; Ferreira, JJ; Lees, A; Rascol, O; Ikedo, F; Magalhaes, D; Rocha, JF; Soares Da Silva, P;
PUBLISHED: 2020, SOURCE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
INDEXED IN: WOS
133
TITLE: Efficacy of Opicapone in Patients with Parkinson's Disease with Levodopa Dose Reduction: a Pooled Post-Hoc Analysis of BIPARK-I and II  Full Text
AUTHORS: Rascol, O; Poewe, W; Ferreira, JJ; Lees, A; Santos, AT; Magalhaes, D; Rocha, JF; Soares Da Silva, P;
PUBLISHED: 2020, SOURCE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
INDEXED IN: WOS
134
TITLE: Reader response: Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial
AUTHORS: Rato, ML; Ferreira, JJ;
PUBLISHED: 2020, SOURCE: NEUROLOGY, VOLUME: 94, ISSUE: 14
INDEXED IN: Scopus WOS
IN MY: ORCID
135
TITLE: Strategies to minimize placebo effects in research investigations
AUTHORS: Rodrigues, FB; Ferreira, JJ;
PUBLISHED: 2020, SOURCE: PLACEBO EFFECTS IN NEUROLOGIC DISEASE, VOLUME: 153
INDEXED IN: Scopus WOS
IN MY: ORCID
136
TITLE: Guidelines on exercise testing and prescription for patients at different stages of Parkinson's disease
AUTHORS: Camilla Martignon; Anna Pedrinolla; Federico Ruzzante; Gaia Giuriato; Fabio Giuseppe Laginestra; Raquel Bouca Machado; Joaquim J Ferreira; Michele Tinazzi; Federico Schena; Massimo Venturelli;
PUBLISHED: 2020, SOURCE: AGING CLINICAL AND EXPERIMENTAL RESEARCH
INDEXED IN: Scopus WOS
IN MY: ORCID
137
TITLE: Neuromelanin Magnetic Resonance Imaging of the Substantia Nigra in Huntington's Disease
AUTHORS: Leitao, R; Guerreiro, C; Nunes, RG; Goncalves, N; Galati, G; Rosario, M; Guedes, LC; Ferreira, JJ; Reimao, S;
PUBLISHED: 2020, SOURCE: JOURNAL OF HUNTINGTONS DISEASE, VOLUME: 9, ISSUE: 2
INDEXED IN: WOS
IN MY: ORCID
138
TITLE: Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology  Full Text
AUTHORS: Oliveira, SR; Dionisio, PA; Guedes, LC; Goncalves, N; Coelho, M; Rosa, MM; Amaral, JD; Ferreira, JJ; Rodrigues, CMP;
PUBLISHED: 2020, SOURCE: BIOMOLECULES, VOLUME: 10, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 35
IN MY: ORCID
139
TITLE: The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis  Full Text
AUTHORS: Fernandes, N; Prada, L; Rosa, MM; Ferreira, JJ; Costa, J; Pinto, FJ; Caldeira, D;
PUBLISHED: 2020, SOURCE: CLINICAL RESEARCH IN CARDIOLOGY, VOLUME: 110, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 30
IN MY: ORCID
140
TITLE: Moving towards home-based community-centred integrated care in Parkinson's disease  Full Text
AUTHORS: Fabbri, M; Caldas, AC; Ramos, JB; Sanchez Ferro, A; Antonini, A; Ruzicka, E; Lynch, T; Rascol, O; Grimes, D; Eggers, C; Mestre, TA; Ferreira, JJ;
PUBLISHED: 2020, SOURCE: PARKINSONISM & RELATED DISORDERS, VOLUME: 78
INDEXED IN: Scopus WOS
IN MY: ORCID
Page 14 of 55. Total results: 548.